Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm
Provided By PR Newswire
Last update: Jan 24, 2025
NEW YORK, Jan. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Akero Therapeutics, Inc. (NASDAQ: AKRO) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Read more at prnewswire.com
